Asia-Pacific Amniotic Products Market, By Product Type (Amniotic Membranes and Amniotic Suspensions), Type (Flowables and Non-Flowables), Application (Wound Care, Orthopedics, Opthalmology, Periodontal, Regenerative Medicine, Prenatal Diagnosis, Stem Cell Biology, Others), Adherance Type (With Sutures and Without Sutures), Site (Topical and Internal), End User (Hospitals, Clinics, Homecare, Research Institutes and Academics and Others), Distribution Channel (Direct Tender and Third Party Distributor), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific) – Industry Trends & Forecast to 2029.
Market Analysis and Insights: Asia-Pacific Amniotic Products Market
Asia-Pacific Amniotic Products market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.0% in the forecast period of 2022 to 2029 and is expected to reach USD 175.15 million by 2029. Use of amniotic products for the treatment of skin and eye disorder and increasing strategic initiatives by key player act as driver for the amniotic products market growth
Amniotic fluid is the protective liquid contained by the amniotic membrane that serves as a cushion for the growing fetus and to facilitate the exchange of nutrients, water, and biochemical products between mother and fetus. Amniotic-derived products, including amniotic membrane and amniotic fluid products, are one subtype of orthobiologic that are being investigated as a potential treatment option through augmentation of joint inflammation and healing. Amniotic membranes (AM) were initially utilized for treatment of skin disorders such as burns, ulcers, and wounds. The presence of wide range of products of the amniotic products used in the treatment of diseases is satisfying the need of the healthcare facilities. The increased technological advancement leads to development of highly efficient amniotic products in the market.
Major factors driving the growth of Asia-Pacific amniotic products market are use of amniotic products for treatment of skin and eye disorder and ongoing research to increase the therapeutics application and the factor which hampers the growth of the amniotic products market includes high cost of amniotic products and procedures and product recall.
The Amniotic Products market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the Amniotic Products market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Amniotic Products Market Scope and Market Size
The amniotic products market is segmented on basis of product type, type, application, adherence type, site, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, the Asia-Pacific amniotic products market is segmented into amniotic membranes and amniotic suspensions. In 2022, amniotic membranes segment is expected to dominate the market due to the presence of wide product portfolio provided by the company.
- On the basis of type, the Asia-Pacific amniotic products market is segmented into flowables and non-flowabales. In 2022, non-flowables segment is expected to dominate the market due to the fact that these are generally used in wound care and ophthalmology which drives this segment of the market.
- On the basis of application, the Asia-Pacific amniotic products market is segmented into wound care, orthopedics, ophthalmology, periodontal, regenerative medicines, prenatal diagnosis, stem cell biology and others. In 2022, wound care segment is expected to dominate the market due to the fact that amniotic membrane (AM) is an attractive method of grafting for wounds as it has unique properties, including anti-inflammatory effects, bacteriostatic, wound protection, decreased scarring, and pain reduction properties, as well as epithelialization initialization capacities which is expected to act as driver for the segment growth in the amniotic market
- On the basis of adherence type, the Asia-Pacific amniotic products market is segmented into with sutures and without sutures. In 2022, without suture is expected to dominate the market due to the fact that without suture product provide more patient compliance which is expected to increase the demand for these product and in the amniotic products market.
- On the basis of site, the Asia-Pacific amniotic products market is segmented into with topical and internal. In 2022, the topical segment is expected to dominate the Asia-Pacific amniotic market traditional used amniotic product in topical areas such as in diabetic wound healing, scar and fire or chemical burns. This is also very patient friendly and requires less complicated procedures which put less burden on patient pocket.
- On the basis of end user, the Asia-Pacific amniotic products market is segmented into hospital, clinics, research institutes, home care and others. In 2022, hospitals segment is expected to dominate the Asia-Pacific amniotic products market due to the fact that it is the primary healthcare service provider for getting these amniotic procedure. The use of amniotic membrane for ocular use or for using them in tendon and ligament repair are mostly procured in hospital along with that the billing of reimbursement for these product is easily attained in hospital which is the major factor for the growth of the segment.
- On the basis of distribution channel, the Asia-Pacific amniotic products market is segmented into direct tender and third party distributor. In 2022, third party distributor is expected to dominate the Asia-Pacific amniotic products market due to the fact that the segment anticipated to boom up in the coming years due to growing demand for amniotic products device products from hospitals, retailers and clinics.
Amniotic Products Market Country Level Analysis
Amniotic Products market is analyzed, and market size information is provided by the product type, type, application, adherence type, site, end user and distribution channel as referenced above.
The countries covered in the Amniotic Products market report are China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, and rest of Asia-Pacific.
Adherance type segment in China of Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2022 to 2029 because due to the increasing healthcare expenditure of the country and also the research application in the field of amniotic products
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities By Major Market Players to Enhance The Awareness for Amniotic Products Treatment is Boosting the Market Growth of Amniotic Products market.
The amniotic products market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2011 to 2020.
Competitive Landscape and Amniotic Products Market Share Analysis
Amniotic products market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to amniotic products market.
The major companies which are dealing in the Amniotic Products MIMEDX, Smith+Nephew, Organogenesis Inc., Integra LifeSciences, Stryker, APPLIED BIOLOGICS, Katena Products. Inc., Lucina BioSciences, Next Biosciences, Skye Biologics Holdings, LLC., Surgenex, LLC., Ventris Medical, LLC., VIVEX Biologics, Inc., StimLabs LLC., LifeCell International Pvt. Ltd., NuVision Biotherapies Ltd., Genesis Biologics, Amnio Technology, LLC., AMNICELL Corporation, LTD. AlloSource domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the amniotic products market.
For instance,
- In September 2020, Smith & Nephew’s subsidiary Osiris Therapeutics, Inc. announced launch of GrafixPL PRIM, a human placental membrane that can be stored at ambient temperatures. The structural matrix, growth factors, and cell viability of GrafixPL PRIME is equivalent to those of Grafix, a cryopreserved placental membrane, but without the constraints of ultra-low temperature storage. This launch helped the company to meet the complex clinical needs of patients and doctors.
Collaboration, product launch, business expansion, award and recognition, joint ventures, and other strategies by the market player is enhancing the company footprints in the amniotic products market which also provides the benefit for organization’s profit growth.
SKU-